Search Results - "MOHAMMEDI, KAMEL"

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis by Potier, Louis, Mohammedi, Kamel, Velho, Gilberto, Roussel, Ronan

“…In a recent meta-analysis of randomized controlled trials of sodium glucose co-transporter 2 inhibitors (SGLT2i) in patients with diabetes, Lin and colleagues…”
Get full text

Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions by Roussel, Ronan, Steg, Philippe Gabriel, Mohammedi, Kamel, Marre, Michel, Potier, Louis

“…Type 2 diabetes is a leading cause of cardiovascular disease (CVD). Observational studies have consistently shown an association between glycaemic level and…”
Get full text

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review by Nativel, Mathilde, Potier, Louis, Alexandre, Laure, Baillet-Blanco, Laurence, Ducasse, Eric, Velho, Gilberto, Marre, Michel, Roussel, Ronan, Rigalleau, Vincent, Mohammedi, Kamel

“…Lower-extremity arterial disease (LEAD) is a major endemic disease with an alarming increased prevalence worldwide. It is a common and severe condition with…”
Get full text

Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes by Mohammedi, Kamel, Pigeyre, Marie, Bosch, Jackie, Yusuf, Salim, Gerstein, Hertzel C

“…The relationship between ankle blood pressure (BP) and cardiovascular disease remains unclear. We examined the relationships between known and new ankle BP…”
Get full text

Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms by Vergès, Bruno, Aboyans, Victor, Angoulvant, Denis, Boutouyrie, Pierre, Cariou, Bertrand, Hyafil, Fabien, Mohammedi, Kamel, Amarenco, Pierre

“…Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with…”
Get full text

Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143 by Ninon, Foussard, Alice, Larroumet, Marie-Amélie, Barbet-Massin, Laurence, Blanco, Kamel, Mohammedi, Thierry, Couffinhal, Sami, Fawaz, Yann, Pucheu, Vincent, Rigalleau

Get full text

Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community by Roussel, Ronan, El Boustany, Ray, Bouby, Nadine, Potier, Louis, Fumeron, Frédéric, Mohammedi, Kamel, Balkau, Beverley, Tichet, Jean, Bankir, Lise, Marre, Michel, Velho, Gilberto

“…Context: Experimental data support a role for vasopressin in metabolic disorders. Objective: We investigated associations of plasma copeptin, a surrogate of…”
Get full text

Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study by Bertrand, Capucine, Saulnier, Pierre-Jean, Potier, Louis, Croyal, Mikaël, Blanchard, Valentin, Gand, Elise, Ragot, Stéphanie, Schneider, Fabrice, Bocock, Olivia, Baillet-Blanco, Laurence, Velho, Gilberto, Marre, Michel, Roussel, Ronan, Rigalleau, Vincent, Hadjadj, Samy, Mohammedi, Kamel

“…Aims/hypothesis The lipid profile has not been fully investigated in individuals with peripheral artery disease (PAD). We aimed to evaluate the relationship…”
Get full text

History of lower-limb complications and risk of cancer death in people with type 2 diabetes by Mohammedi, Kamel, Harrap, Stephen, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Chalmers, John, Woodward, Mark

“…Individuals with diabetes and lower-limb complications are at high risk for cardiovascular and all-cause mortality, but uncertainties remain in terms of…”
Get full text

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review by Mahé, Guillaume, Aboyans, Victor, Cosson, Emmanuel, Mohammedi, Kamel, Sarlon-Bartoli, Gabrielle, Lanéelle, Damien, Mirault, Tristan, Darmon, Patrice

“…Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is highly prevalent in patients with type 2 diabetes mellitus (T2DM)…”
Get full text

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes by Mohammedi, Kamel, Woodward, Mark, Marre, Michel, Colagiuri, Stephen, Cooper, Mark, Harrap, Stephen, Mancia, Giuseppe, Poulter, Neil, Williams, Bryan, Zoungas, Sophia, Chalmers, John

“…Microvascular disease is associated with a high risk of macrovascular events in patients with type 2 diabetes, but the impact of macrovascular disease on the…”
Get full text

Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records by Mohammedi, Kamel, Cordon, Audrey, Rigalleau, Vincent, Foussard, Ninon, Bairras-Martin, Céline, Couffinhal, Thierry, Bezin, Julien, Benard, Antoine

Get full text

Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study by Mohammedi, Kamel, Fauchier, Laurent, Quignot, Nadia, Khachatryan, Artak, Banon, Tamar, Kapnang, Raissa, Kikuchi, Kazue, Ren, Hongye, Massien, Christine, Vigié, Lucile, Larsen, Sara, Sibon, Igor

“…People with type 2 diabetes (T2D) are at elevated risk of cardiovascular disease (CVD) including stroke, yet existing real-world evidence (RWE) on the clinical…”
Get full text

The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures by Alkhami, Fadi, Borderie, Gauthier, Foussard, Ninon, Larroumet, Alice, Blanco, Laurence, Barbet-Massin, Marie-Amélie, Ferriere, Amandine, Ducos, Claire, Mohammedi, Kamel, Fawaz, Sami, Couffinhal, Thierry, Rigalleau, Vincent

“…Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants…”
Get full text

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes by Velho, Gilberto, Ragot, Stéphanie, El Boustany, Ray, Saulnier, Pierre-Jean, Fraty, Mathilde, Mohammedi, Kamel, Fumeron, Frédéric, Potier, Louis, Marre, Michel, Hadjadj, Samy, Roussel, Ronan

“…Cardiovascular disease and kidney damage are tightly associated in people with type 2 diabetes. Experimental evidence supports a causal role for vasopressin…”
Get full text

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes by Mohammedi, Kamel, Marre, Michel, Hadjadj, Samy, Potier, Louis, Velho, Gilberto

“…End-stage kidney disease (ESKD) is a multifactorial condition influenced by genetic background, but the extent to which a genetic risk score (GRS) improves…”
Get full text

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes by Sanchez, Manuel, Kannengiesser, Caroline, Hoang, Sophie, Potier, Louis, Fumeron, Frédéric, Venteclef, Nicolas, Scheen, André, Gautier, Jean-François, Hadjadj, Samy, Marre, Michel, Roussel, Ronan, Mohammedi, Kamel, Velho, Gilberto

“…Abstract Background Type 1 diabetes is associated with accelerated vascular aging and advanced atherosclerosis resulting in increased rates of cardiovascular…”
Get full text

Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population by Petria, Iulia, Albuquerque, Samuel, Varoquaux, Gaël, Vie, Jill-Jênn, Venteclef, Nicolas, Mohammedi, Kamel, Roussel, Ronan, Camoin, Marion, Perseghin, Gianluca, Velho, Gilberto, Potier, Louis

“…Cardiovascular risk and body-weight management are both emerging challenges of type 1 diabetes care. We evaluated the association between intraindividual…”
Get full text

Gut Microbiota and Mycobiota Evolution Is Linked to Memory Improvement after Bariatric Surgery in Obese Patients: A Pilot Study by Enaud, Raphaël, Cambos, Sophie, Viaud, Esther, Guichoux, Erwan, Chancerel, Emilie, Marighetto, Aline, Etchamendy, Nicole, Clark, Samantha, Mohammedi, Kamel, Cota, Daniela, Delhaes, Laurence, Gatta-Cherifi, Blandine

“…Patients with obesity are known to exhibit gut microbiota dysbiosis and memory deficits. Bariatric surgery (BS) is currently the most efficient anti-obesity…”
Get full text

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus by Potier, Louis, Chequer, Renata, Roussel, Ronan, Mohammedi, Kamel, Sismail, Souad, Hartemann, Agnès, Amouyal, Chloé, Marre, Michel, Le Guludec, Dominique, Hyafil, Fabien

“…Albuminuria is of one the strongest predictors of cardiovascular disease (CVD) in diabetes. Diabetes is associated with cardiac microvascular dysfunction…”
Get full text